News
Archive
New Science Ventures announces merger of its portfolio company Achronix with ACE Convergence
NorthSea Therapeutics reports Positive Phase 2b interim results for icosabutate in NASH patients
Resolve Therapeutics announces clinically meaningful improvement in patients with Systemic lupus erythematosus in Phase 2a clinical trial
Resolve Therapeutics publishes positive Sjogren’s syndrome clinical trial results
NorthSea Therapeutics doses first patient in Phase 1 trial of SEFA-1024 in dyslipidemia and further expands its clinical pipeline
ProterixBio Announces Commercial Availability of a Semi-Quantitative COVID-19 Antibody Test
Back To News
October 27, 2017
State of Artificial Intelligence for Enterprises
Business leaders looking for increased revenue, more efficiency and a better experience for their customers can have all of that — if they adopt artificial intelligence (AI) for their organization. That is the promise of AI that many businesses are actively investing in today. There is a huge disruption among many enterprises at an ever-increasing … Continue reading “State of Artificial Intelligence for Enterprises”
The post State of Artificial Intelligence for Enterprises appeared first on Fuzzy Logix.